Bioresorbable Vascular Scaffold: A Pioneering Solution for In-Stent Restenosis of stent fracture on right coronary artery

Francesco Granata, Elisabetta Moscarella, Luigi Caliendo, Attilio Varricchio


Stent fracture (SF) is a rare adverse complication that might occur in peripheral and coronary artery, particularly with sirolimus-eluting stent (SES). The structural characteristics of this device with closed cell design and stainless steel scaffolding prompts to a probable fracture of stent. This   adverse event is strongly associated with in-stent restenosis (ISR), target lesion revascularization (TLR) and stent thrombosis (ST). We report the fluoroscopic and tomographic patterns of fractured stent associate with restenosis and thrombotic sub-occlusion treated by bioresorbable vascular scaffold (BVS). To our knowledge, this is the first published report of SF that was treated by BVS.

Full Text:



Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol. 2009;103:923-9.

Mamas A, Foin N, Abunassar C, Khan MA, Di Mario C, Fraser DG. Stent Fracture: Insights on Mechanisms, Treatments, and Outcomes From the Food and Drug Administration Manufacturer and User Facility Device Experience Database. Catheterization and Cardiovascular Interventions 83:E251–E259 (2014).

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4



  • There are currently no refbacks.

Copyright (c) 2016 Francesco Granata, Elisabetta Moscarella, Luigi Caliendo, Attilio Varricchio

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN: 2518-6140 (on-line version)